Belorgey Didier, Sharp Lynda K, Crowther Damian C, Onda Maki, Johansson Jan, Lomas David A
Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, UK.
Eur J Biochem. 2004 Aug;271(16):3360-7. doi: 10.1111/j.1432-1033.2004.04270.x.
The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.
伴有神经丝氨酸蛋白酶包涵体的痴呆型家族性脑病(FENIB)由神经丝氨酸蛋白酶基因突变引起。我们已经证明了突变的预测效应与脑内包涵体数量之间的相关性,以及与疾病发病年龄的负相关关系。我们之前的研究表明,FENIB中的神经元内包涵体是由一个神经丝氨酸蛋白酶分子的反应中心环与下一个分子的β-折叠A之间的顺序相互作用形成的。我们在此表明,导致严重形式FENIB的波特兰神经丝氨酸蛋白酶(Ser52Arg)也会形成环-片层聚合物,但速度更快,这与更严重的临床表型相符。波特兰突变体在尿素中具有正常的解折叠转变和正常的解链温度,但作为蛋白酶抑制剂无活性。这部分是由于反应环处于较难与靶酶组织型纤溶酶原激活剂结合的构象。这些结果与圆二色性分析结果一致,表明波特兰神经丝氨酸蛋白酶的反应中心环部分插入β-折叠A中,以采用类似于聚合途径中间产物的构象。我们的数据为与波特兰神经丝氨酸蛋白酶相关的FENIB中的包涵体数量和痴呆严重程度提供了解释。此外,突变体的无活性可能导致组织型纤溶酶原激活剂的活性不受控制,从而解释了在病情更严重的个体中出现的癫痫发作。